Proteasome-dependent degradation of the human estrogen receptor.
about
Estrogen receptor of primary breast cancers: evidence for intracellular proteolysisEDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage responseThe catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcriptionThe transcriptional repressor protein PRH interacts with the proteasomeIdentification of the MLL2 complex as a coactivator for estrogen receptor alphaHormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responsesmiR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNARegulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancerEndogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells.The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptorRegulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylationPrenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.Coordinate regulation of RARgamma2, TBP, and TAFII135 by targeted proteolysis during retinoic acid-induced differentiation of F9 embryonal carcinoma cellsLigand-induced estrogen receptor alpha degradation by the proteasome: new actors?Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis.Drugging the undruggables: exploring the ubiquitin system for drug developmentEstrogens induce rapid cytoskeleton re-organization in human dermal fibroblasts via the non-classical receptor GPR30Regulation of Estrogen Receptor α by the SET7 Lysine MethyltransferaseStructural Basis for Ca2+-induced Activation and Dimerization of Estrogen Receptor by CalmodulinMetastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cellsLoss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor αBasic principles and emerging concepts in the redox control of transcription factorsCharacterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cellsc-Src-null mice exhibit defects in normal mammary gland development and ERalpha signalingEstrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemiaExtracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction.Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complexGenetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction.Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action.Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins.Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status.Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity.UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells.The UPS: a promising target for breast cancer treatment.Estrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint.Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnoverIsoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland developmentLiver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1.Non-monotonic dose responses in studies of endocrine disrupting chemicals: bisphenol a as a case study
P2860
Q21195159-9BCA775D-645B-4E30-AF47-977857D6206AQ24297469-4C71DBF0-3011-4381-86E9-9DE1AD42458EQ24301763-44BCA69C-F931-47F2-B370-8543EA830998Q24306300-A7356D8A-B0B0-4C25-A6C2-2BEF18C340DCQ24316007-333F62C7-EC43-4A30-BF58-7069DA814F69Q24613799-55D37437-BA5A-414F-8F29-9B8FB78FED8AQ24644154-4896C13D-A5B5-4735-837D-6E2FEDEF31B7Q24646768-9E70B094-FED5-4772-912E-5EEB6C68AE74Q24680130-2A4D3DF5-305D-4C68-BE2C-D446A944522AQ24682781-15E26FC8-29EB-4ADF-8B70-75E685D855D8Q24793292-8CA8FEA7-6718-4AC6-B363-AA8F7E890C7AQ24796687-AC673E48-61E5-44A2-829F-C0FFE0C4D2BBQ24797549-F36DCD11-F06F-4887-AA1C-A88AE55EA4A6Q25257822-FEA8DF73-6661-443F-B802-A8ABDB26EB99Q25257858-0D8730A7-BDD5-4439-A961-6ADC2086F9E7Q26752823-4878C123-6280-493B-8785-E21ED83F6618Q27311338-77964935-04B7-499E-9790-5DB86A4A057EQ27650581-A3AF0237-0ECD-4BA0-A353-B21C09731A85Q27676878-5D71D093-B2D6-48FD-BE25-D52FD440D0D3Q28237005-539A8808-8814-4A4D-853F-07438E5AC128Q28308069-C9A3ED15-47B6-4F4E-BF91-071D96C44F86Q28391506-065B0809-13ED-4161-A321-92D68E42BC79Q28475502-5CB6C838-7CA9-4220-8B65-6171E90D8645Q28504741-F3D28FD0-06F9-4C0F-8AD7-1851C1DE1CEEQ28569397-566322E2-92E4-4FA3-8778-CB9356E7CD76Q28580406-C19876C6-2F30-422F-8BC1-EEFC348463D5Q28582161-A9584F85-9DC1-4CD0-9117-5D4C05D9C024Q28593439-88140865-CFD3-4814-898B-4BC67ACD0E97Q30373162-7220FC95-1A98-4D9E-AF5A-D5A4478198BFQ30408703-3DF0D590-C837-49DB-8674-B8F3BB9CD586Q30450954-24BE328B-FF6C-499E-91F5-DBA64F274932Q31097623-659EF731-CF43-4FDA-BB84-5D7BDB7DA4A3Q31813156-899BEED1-93C5-4C72-BFAC-DAFBFB7E8AE8Q33292171-4FAA7C64-82F2-4A40-B8CB-0D111B6898C0Q33384289-B51C2717-0C79-4F42-8EA2-04D3743F4579Q33521510-5797FFB0-024C-4573-864F-4C7BE5E0E297Q33611408-A3C5EEFD-EE58-4650-9960-B7FBB5DB836DQ33637204-87C4A530-9C7E-422A-8909-5710F951F1E1Q33642453-A4D4849D-5BCF-4ED9-8613-93FACE888976Q33676877-F652D020-02AE-4925-B8F3-34970ED2E537
P2860
Proteasome-dependent degradation of the human estrogen receptor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteasome-dependent degradation of the human estrogen receptor.
@en
Proteasome-dependent degradation of the human estrogen receptor.
@nl
type
label
Proteasome-dependent degradation of the human estrogen receptor.
@en
Proteasome-dependent degradation of the human estrogen receptor.
@nl
prefLabel
Proteasome-dependent degradation of the human estrogen receptor.
@en
Proteasome-dependent degradation of the human estrogen receptor.
@nl
P2093
P2860
P356
P1476
Proteasome-dependent degradation of the human estrogen receptor.
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.5.1858
P407
P577
1999-03-01T00:00:00Z